Biologics
Chime Biologics and Hope Medicine Accelerate First-in-Class Antibody Drug HMI-115 for Endometriosis and Androgenic Alopecia
Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services for Hope Medicine...
October 27, 2023 | News
Biotium Introduces New Highly-Selective Stains For Both Gram-Positive and Gram-Negative Bacteria
Biotium, a leading innovator of fluorescent dyes for life science research, proudly announces the launch of its breakthrough ...
October 26, 2023 | News
Lonza's Rapid PyroCell® Enhances Rabbit-Free Pyrogen Testing
Lonza launched PyroCell® MAT Rapid System and PyroCell® MAT Human Serum (HS) Rapid System, two sustainable monocyte activation test (MAT) systems...
October 25, 2023 | News
Polyplus Expands LipidBrick® Library to Optimize LNP Formulation for mRNA Therapeutics
LNPs have demonstrated high efficiency delivering RNA therapeutics in vivo, but they can be hard to modulate with challenges in the biodistributi...
October 25, 2023 | News
Australia's Certa Therapeutics: FT011 Granted US FDA Orphan Drug Status for Systemic Sclerosis
Orphan Drug Designation is granted by the FDA to investigational therapies addressing rare medical diseases or conditions that affect fewer than 200,000 pe...
October 24, 2023 | News
OBiO and Refreshgene Join Forces for Gene Therapy Product Commercialization
Under the agreement, OBiO leverages its capabilities of process development, large-scale cGMP commercial production and global business development to prov...
October 24, 2023 | News
Daiichi Sankyo and MSD Collaborate on Three Global DXd ADCs
Collaboration combines Daiichi Sankyo’s proven ADC expertise and DXd technology with MSD’s deep experience in oncology and clinical developme...
October 23, 2023 | News
FDA Approves PENBRAYA™: First Vaccine for 5 Common Meningococcal Serogroups in Teens
PENBRAYA™ provides the broadest serogroup coverage (meningococcal groups A, B, C, W and Y) of any meningococcal vaccine available in the U.S. ...
October 23, 2023 | News
Endeavor BioMedicines Licenses HER3-Targeted ADC Worldwide Rights from Hummingbird Bioscience
Endeavor obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-HER3 ADC to be developed for patients with HER3-expressing tumors Hum...
October 20, 2023 | News
Complete Genomics and Integrated DNA Technologies Forge New NGS Product Ecosystem
"High-throughput sequencing is a multi-step process that demands high accuracy and performance while maintaining an easy-to-use workflow. This partnership ...
October 19, 2023 | News
SOPHiA GENETICS Partners with MSKCC and AstraZeneca for Global Cancer Care Equality
SOPHiA GENETICS (Nasdaq: SOPH), a category-defining software company and a global leader in data-driven medicine today announced a collaboration with&...
October 19, 2023 | News
WuXi XDC and HKSTP Collaborate to Boost Bioconjugate Drug Industry in Hong Kong
Hong Kong Science and Technology Parks Corporation (HKSTPC) and WuXi XDC signed a cooperation framework agreement to jointly promote ...
October 18, 2023 | News
Revvity and Element Biosciences Collaborate to Enhance NGS Research Workflow
Next generation sequencing workflow with research use only components from both companies is designed to provide flexibility, time and cost savings on sa...
October 17, 2023 | News
Coriolis Pharma Announces Strategic Growth Partnership With KKR and Frontier Biosolutions
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprint Newly formed KKR platform Frontier Biosolutio...
October 16, 2023 | News
Most Read
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
